medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2006, Number 1

<< Back Next >>

Acta Med 2006; 4 (1)

Prevalence of peripheral neuropathy in diabetes mellitus

Aliss SJA, Cervantes RMZ, Ibarra OA, González BD

Language: Spanish
References: 15
Page: 13-17
PDF size: 97.41 Kb.


ABSTRACT

Aim: To determine the prevalence of peripheral neuropathy (NP) in diabetics type 1 and 2 taken care for in the Hospital de Especialidades CMN La Raza (HE CMNR) and its association with the age, time of evolution and degree of metabolic control. Material and methods: 100 patients sent to the clinic of Diabetes of Endocrinology Department were studied. A neurological physical examination was assessed in search of NP, assigning a qualification according it the severity at the same time glycated hemoglobin was assessed (HbA1c). Results: Total prevalence of NP was of 81%; in the diabetics type 2 it was of 95% and 69% type 1, being more severe en the diabetics type 2. Correlation existed positive between presence of NP and the time of evolution of the disease, as the NP and the age of the patient. Conclusion: The prevalence of NP in this one group was elevated because it is a reference hospital, it was more frequent and severe in patients with DM type 2. The time of evolution from the diagnosis of the disease and the age of the patient is a factors that more correlate with the presence and severity of the NP.


REFERENCES

  1. Feldman E. Clinical manifestations and diagnosis of diabetic polyneuropathy. www.uptodate.com.2002; up to date on line 10.2

  2. Sean P, O’Brien MB. Peripheral Neuropathies in diabetes. Diabetes Care 2001; 3: 121-126.

  3. Aristidis V, George K. Can VEGF reverse diabetic neuropathy in human subjects? J Clin Invest 2001; 107: 1215-1218.

  4. Sheetz MJ, King GL. Molecular under-standing of hyperglycemia’s adverse effects for diabetic complications. JAMA 2002; 228: 2579-2588.

  5. Suzuki C, Ozaki I, Tanoxaki M et al. Peripheral and central conduction abnormalities in diabetes mellitus. Neurology 2000; 54: 1932-1937.

  6. Sonja K, Martin B, Freeman M. Neural and endothelial control of the microcirculation and diabetic peripheral neuropathy. Neurology 2000; 54: 1246-1252.

  7. Feldman E, Stevens M, Thomas P et al. Practical two-step quantitative clinical and electrophysiological Assessment for the diagnosis and Staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.

  8. Moreno F, Vargas R, Frati A et al. Prevalencia de neuropatía en diabetes mellitus tipo 2 en México. Med Int Mex 1992; 8 Abs.

  9. Brimijoin S. Transporte axónico en la neuropatía diabética. En: Dyck P, Thomas P. Neuropatía diabética. 2ª Edición. 2000: 362-373.

  10. Daule J. Pruebas electrofisiológicas en la neuropatía diabética. En: Dyck P, Thomas P. Neuropatía diabética. 2ª Edición. 2000: 235-253.

  11. Suárez G, Dyck P. Valoración sensitiva cuantitativa. En: Dyck P, Thomas P. Neuropatía diabética. 2ª Edición. 2000: 162-181.

  12. Vallancourt P, Langevin H. Painful Peripheral Neuropathies. Medical Clinic of North America 1999; 83: 627-642.

  13. Franklin G M, Kahn L B, Baxter J et al. Sensory Neuropathy in non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes. Am J Epidemiol 1990; 131: 633.

  14. Dick PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic naturopathic, retinopathy, and nephropathy in population-based cohort: The Rochester Diabetic Naturopathic Study. Neurology 1993; 43: 817.

  15. Maser RE, Steekiste AR, Dorman JS et al. Epidemiological correlates of Diabetic Neuropathy: Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456.




2020     |     www.medigraphic.com